The Latest
-
Robert Way via Getty Images
AstraZeneca drug could help keep a common breast cancer at bay
Data presented at ASCO show that swapping in the oral drug camizestrant for an older therapy helped sustain the benefit of initial treatment, potentially opening a novel step in patient care.
-
Courtesy of Boston Scientific
Boston Scientific plans changes to expected $200M tariff hit as situation shifts
The company also shared more details of its exit from the TAVR market and the impact of FDA layoffs on product review times.
-
Andrew Harnik / Staff via Getty Images
TrackerTrump policies are upending healthcare. Track the effect on the medtech industry here.
AdvaMed’s CEO praised comments from FDA chief Martin Makary about Medicare covering breakthrough devices more quickly. Elsewhere, a court halted most of Trump’s tariff plans, but an appeals court blocked the ruling.
Updated May 30, 2025 -
ventdusud via Getty Images
The medtech IPO window is finally open. Or is it?
After a three-year IPO drought, the industry is questioning whether the window for medtech public offerings is open following a small burst of activity.
Updated 2 hours ago -
US court blocks Trump’s sweeping tariffs
The Court of International Trade said the president overstepped his authority, halting various duties. After an appeal, the ruling has been paused.
Updated May 29, 2025 -
Mario Tama / Staff via Getty Images
Masimo says cyberattack will not prevent it from fulfilling orders
The maker of patient monitoring devices said the incident will not have a material effect on its updated financial outlook.
-
Permission granted by Abbott
Abbott wins FDA approval for mitral valve replacement device, teeing up Edwards competition
Abbott said the Tendyne system addresses a significant unmet need in cardiac care, providing an option for patients ineligible for open heart surgery and whose valves cannot be successfully repaired with MitraClip.
-
Courtesy of Boston Scientific
Boston Scientific ends TAVR sales; J&J shares Monarch robot data
Boston Scientific said it would halt worldwide sales of its Acurate devices due to “increased clinical and regulatory requirements.”
-
Sarah Silbiger via Getty Images
FDA finds Chinese lab copied or falsified data, endangering patients
The FDA said the findings raise doubts about the reliability and viability of premarket submissions based on the company’s data.
-
Courtesy of Zimmer Biomet
Zimmer hires former Nevro CEO Kevin Thornal
Thornal will join the orthopedics company as group president for global businesses and the Americas, a newly created position.
-
Permission granted by Becton Dickinson
BD recalls esophagogastric tubes linked to 2 serious injuries, 1 death
A problem when preparing the devices for use can delay diagnosis or treatment, leading BD to update its instructions.
-
Tasos Katopodis via Getty Images
Trump calls for 50% tariffs on EU
The duties are slated to take effect July 9 as the bloc and the U.S. reengage on trade talks, the president said.
Updated May 27, 2025
